Health economics experts. Managed care professionals. Key clinical specialists. This is where the worlds of clinical, regulatory, and economical outcomes for specialized pharmaceutical biotechnology meet: The Center for Biosimilars is your online resource for emerging technologies, with a focus on improving critical thinking in the field to impact patient outcomes. We’ll discuss the current landscape for advanced health care management—reviewing emerging treatment paradigms, approaches, and considerations—all by authoritative industry voices.
Company Details
- Founded
- -
- Address
- Cranbury, Nj
- Industry
- Book And Periodical Publishing
- NAICS
-
Publishing Industries (except Internet)Newspaper, Periodical, Book, and Directory PublishersDirectory and Mailing List PublishersOther PublishersGreeting Card PublishersAll Other Publishers
- Website
- centerforbiosimilars.com
- HQ
- Cranbury, NJ
The Center For Biosimilars Questions
The Center For Biosimilars's website is centerforbiosimilars.com
The Center For Biosimilars's LinkedIn profile is https://www.linkedin.com/company/thecenterforbiosimilars
The Center For Biosimilars's industry is
Book and Periodical Publishing
The Center For Biosimilars's top competitors are
Biosimilar Development,
Teva Pharmaceuticals,
Biosimilars Forum,
Act4biosimilars,
Generics And Biosimilars Initiative (Gabi),
Medicines For Europe,
Igba - International Generic And Biosimilar Medicines Association,
Association For Accessible Medicines,
Fda,
Biosimilars Council.
The Center For Biosimilars's categories are Book and Periodical Publishing
The Center For Biosimilars's founding year is 2016
